Pharma Industry News Weekly Recap: September 1, 2023

2023-09-01T06:55:02-07:004IR, AI, Biden, Cancer, Cardiovascular, COVID-19, Diabetes, Digital Health, Digital Innovation, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Machine Learning, Medical Marijuana, Obesity, Opioids, Politics, Private Equity & Venture Capital, Regulatory, Research, Vaccines|

// Biotech and Pharma Therapeutics BMS publishes 'modest' multiple myeloma survival data on heir to Revlimid, Pomalyst August 30, [...]

Pharma Industry News Weekly Recap: March 10, 2023

2023-03-10T10:50:08-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics With PCSK9 pill, Merck aims to succeed where others failed March 7, 2023 / [...]

Pharma Industry News Weekly Recap: March 3, 2023

2023-03-03T10:18:48-08:003D Printing, 4IR, adipose, AI, Alzheimer's, Biden, Biopharmaceutical Business Development, Cancer, Cardiovascular, Cell Therapy, COVID-19, Diabetes, Digital Health, Drug Discovery, Drug Pricing, FDA, Gene Therapy, Heart Failure, Industry News, Insulin, Medical Marijuana, Mergers, Obesity, Oncology, Opioids, Politics, Women's Health|

// Biotech and Pharma Therapeutics After spending $6.5B for Momenta, J&J readies 'pipeline in a product' for pivotal year [...]

Go to Top